The MAQUET line of FUSION grafts merges ePTFE with PET to offer vascular surgeons the best of both materials: the easy handling of ePTFE and the minimal suture hole bleeding seen in knit polyester ...

DURHAM, N.C., April 18, 2023 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at ...

MADISON — Scientists at the Wisconsin National Primate Research Center (WNPRC) and the Morgridge Institute for Research at the University of Wisconsin–Madison have been at the forefront of stem cell ...

SAN FRANCISCO (MarketWatch) -- Angiotech Pharmaceuticals Inc. said Thursday that it has agreed to pay $14 million cash for Edwards Lifesciences Corp.'s Lifespan ePTFE vascular graft business. The deal ...

FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates (GORE) today announced that the U.S. Food & Drug Administration (FDA) has given the company clearance to market its GORE PROPATEN Vascular ...

During the evolution of the various tissue-engineered approaches, there has been a tendency to report imminent clinical applicability before essential milestones have been reached. At a minimum, we ...

LONDON, June 15, 2021 (GLOBE NEWSWIRE) -- According to The Business Research Company’s vascular graft market research report, the vascular grafts market consists of sales of vascular grafts and ...

Global Man made Vascular Graft Market Size was estimated at USD 3430.67 million in 2021 and is projected to reach USD 5042.41 million by 2028, exhibiting a CAGR of 5.66% during the forecast period.

Company also provides update on enrollment progress in Phase 2/3 vascular trauma trial DURHAM, N.C., April 18, 2023 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology ...